Is ARS Pharmaceuticals Inc (NASDAQ: SPRY) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

SPRY belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of ARS Pharmaceuticals Inc is $1.41B. A total of 0.68 million shares were traded on the day, compared to an average of 1.09M shares.

In the most recent transaction, Tanimoto Sarina sold 100,000 shares of SPRY for 13.83 per share on Oct 08 ’24. After the transaction, the CHIEF MEDICAL OFFICER now owns 1,346,494 company shares. In a previous transaction on Oct 08 ’24, Lowenthal Richard E sold 100,000 shares at 13.83 per share. SPRY shares that PRESIDENT AND CEO owns now total 1,346,494.

Among the insiders who sold shares, Karas Eric disposed of 10,000 shares on Sep 18 ’24 at a per-share price of $14.00. This resulted in the Chief Commercial Officer holding 5,693 shares of SPRY after the transaction. In another insider transaction, Tanimoto Sarina sold 100,000 shares at $12.93 per share on Sep 17 ’24. Company shares held by the CHIEF MEDICAL OFFICER now total 1,398,499.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SPRY has a high of $16.50 and a low of $3.35.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SPRY’s latest balance sheet shows that the firm has $60.06M in Cash & Short Term Investments as of fiscal 2021. There were $9.03M in debt and $8.19M in liabilities at the time. Its Book Value Per Share was $2.22, while its Total Shareholder’s Equity was -$31.27M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SPRY is Buy with a score of 5.00.

Most Popular

Related Posts